| Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network A Smith, D Howell, R Patmore, A Jack, E Roman British journal of cancer 105 (11), 1684-1692, 2011 | 899 | 2011 |
| Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab S Barrans, S Crouch, A Smith, K Turner, R Owen, R Patmore, E Roman, ... Journal of clinical oncology 28 (20), 3360-3365, 2010 | 728 | 2010 |
| Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network A Smith, S Crouch, S Lax, J Li, D Painter, D Howell, R Patmore, A Jack, ... British journal of cancer 112 (9), 1575-1584, 2015 | 465 | 2015 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 455 | 2020 |
| Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project LM Morton, SL Slager, JR Cerhan, SS Wang, CM Vajdic, CF Skibola, ... JNCI Monographs 2014 (48), 130-144, 2014 | 356 | 2014 |
| Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report SE Lacy, SL Barrans, PA Beer, D Painter, AG Smith, E Roman, SL Cooke, ... Blood, The Journal of the American Society of Hematology 135 (20), 1759-1771, 2020 | 347 | 2020 |
| Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia K Sibley, S Rollinson, JM Allan, AG Smith, GR Law, PL Roddam, ... Cancer research 63 (15), 4327-4330, 2003 | 249 | 2003 |
| Epidemiology of lymphomas E Roman, AG Smith Histopathology 58 (1), 4-14, 2011 | 244 | 2011 |
| Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium A Rosenwald, S Bens, R Advani, S Barrans, C Copie-Bergman, ... Journal of Clinical Oncology, JCO1900743, 2019 | 209 | 2019 |
| Etiologic heterogeneity among non-Hodgkin lymphoma subtypes LM Morton, SS Wang, W Cozen, MS Linet, N Chatterjee, S Davis, ... Blood 112 (13), 5150-5160, 2008 | 202 | 2008 |
| Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma JR Cerhan, SI Berndt, J Vijai, H Ghesquières, J McKay, SS Wang, Z Wang, ... Nature genetics 46 (11), 1233-1238, 2014 | 187 | 2014 |
| Analysis of heritability and shared heritability based on genome-wide association studies for 13 cancer types JN Sampson, WA Wheeler, M Yeager, O Panagiotou, Z Wang, SI Berndt, ... Journal of the National Cancer Institute 107 (12), djv279, 2015 | 181 | 2015 |
| Tumor necrosis factor (TNF) and lymphotoxin-α (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium CF Skibola, PM Bracci, A Nieters, A Brooks-Wilson, S De Sanjosé, ... American journal of epidemiology 171 (3), 267-276, 2010 | 155 | 2010 |
| Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network DA Howell, AG Smith, A Jack, R Patmore, U Macleod, E Mironska, ... BMC Blood Disorders 13, 1-9, 2013 | 147 | 2013 |
| Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy JM Allan, AG Smith, K Wheatley, RK Hills, LB Travis, DA Hill, DM Swirsky, ... Blood 104 (13), 3872-3877, 2004 | 139 | 2004 |
| The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research A Smith, E Roman, D Howell, R Jones, R Patmore, A Jack, ... British journal of haematology 148 (5), 739-753, 2010 | 128 | 2010 |
| Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region CF Skibola, SI Berndt, J Vijai, L Conde, Z Wang, M Yeager, ... The American Journal of Human Genetics 95 (4), 462-471, 2014 | 127 | 2014 |
| Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy DA Howell, E Roman, H Cox, AG Smith, R Patmore, AC Garry, ... BMC palliative care 9, 1-8, 2010 | 127 | 2010 |
| Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma TJ Lightfoot, CF Skibola, AG Smith, MS Forrest, PJ Adamson, GJ Morgan, ... Haematologica 91 (9), 1222-1227, 2006 | 126 | 2006 |
| The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort M Stahl, M DeVeaux, T de Witte, J Neukirchen, MA Sekeres, AM Brunner, ... Blood advances 2 (14), 1765-1772, 2018 | 122 | 2018 |
